Funded Tech Companies

Synuca Therapeutics

Researching who provided funding to Synuca Therapeutics? Lundbeckfonden BioCapital joined the equity holders in this innovative biopharmaceutical company.

Company Overview

Company Name
Synuca Therapeutics
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
Ole Maaløes Vej 3
Copenhagen, 2200
Denmark
Phone
Undisclosed
Email Address
Not Recorded

Company Background Information

Overview
SynuCa Therapeutics combines decades of groundbreaking research in P-type ATPases and neuroscience from Aarhus University to propose a novel disease-modifying treatment for patients suffering from Parkinson's Disease and associated disorders. By targeting the SERCA calcium transporter, our first-in-class small molecules salvage the root disease cause by repairing the neuronal calcium imbalances caused by pathological a-Synuclein brain species.
Profile
Synuca Therapeutics LinkedIn Company Profile
Social Media
Synuca Therapeutics Company Twitter Account
Company News
Synuca Therapeutics News
Facebook
Synuca Therapeutics on Facebook
YouTube
Synuca Therapeutics on YouTube
Last Transaction
3/3/2026

Financing History

Date
Type
Amount
Venture Equity
$49,000,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Lasse Reimer
  Lasse Reimer LinkedIn Profile  Lasse Reimer Twitter Account  Lasse Reimer News  Lasse Reimer on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Syntropic Medical | Synup

 

Share this article

 


About Our VC & M&A Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary